Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AFFINITY: rVIII-SingleChain vs Octocog alfa in Hemophilia A
NCT01486927Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Feb 2012
- Primary completion
- Dec 2014
- Modality
- Monoclonal Antibodies
- Countries
- 20
01
Overview
A Phase 3 trial of lonoctocog alfa in hemophilia A, sponsored by CSL Limited. Started Feb 2012; status: completed.
02
Drugs
lonoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT01486927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01486927.